However, the extent to which either of these mechanisms are actually responsible for GRK5-dependent cardiac hypertrophy in vivo and whether they represent the only means by which GRK5 promotes hypertrophy is not known. The gene discussed is GRK5; the disease is cardiac hypertrophy.